Canada Cosmetic Notification Consultant

Scope and evidence must be confirmed before any paid tests or filings.

A Canada cosmetic notification consultant is most valuable before a form is filed: the first questions are whether the product is legally a cosmetic, who is the manufacturer or importer for Canadian purposes, and what evidence is missing. A Cosmetic Notification Form (CNF) is not a licence, approval or safety certificate.

Under section 30 of the Cosmetic Regulations, manufacturers and importers must notify Health Canada no later than 10 days after first sale in Canada. The legal deadline is not a ten-day approval process. Classification, safety, ingredient restrictions and compliant labels have to be considered separately before sale.

Choose the Canadian regulatory route before preparing a Cosmetic Notification Form

Screen the complete product presentation (pack, product page, adverts and claims), composition, intended site of use and mechanism of action. Health Canada evaluates ambiguous cosmetic–drug cases individually; a familiar cosmetic format alone does not decide the regime.

Route matrix: what changes the classification

Observed facts	Provisional route	Question or evidence that decides
Moisturizer or shampoo; cleansing/beautifying claims only.	Potential cosmetic → conduct Hotlist, safety and label review, then plan CNF.	Final INCI and concentrations; all English/French sales claims; use and exposure.
“Treats eczema/acne”, sun protection/SPF, or another therapeutic claim.	Classification hold → assess drug or natural health product route; do not rely on CNF.	Claim wording, actives, dosage, mechanism and Health Canada interface guidance.
Insect-repellent or pest-control claim.	Classification hold → assess pest-control regime; CNF is not a substitute.	All label/advertising claims and intended pest-control effect.
Existing Canadian Cosmetic Number, changed formula/name/contact, or stopped selling.	Check amendment or discontinuation, rather than automatically filing a new CNF.	Previous submission, CN, dated change record and Canadian sales status.

Identify the legally relevant Canadian party

The CNF must identify the relevant manufacturer/importer and the formulator where applicable; section 30(2)(f) requires a Canadian address of the manufacturer or importer. Health Canada’s guide says the online form has required that Canadian address since 5 March 2025. A consultant may complete the notification on an authorised party’s behalf, but being the notifier/agent does not by itself make the consultant the statutory manufacturer or importer. Document the importer, brand owner, any Canadian authorised representative, contract formulator, label contact and each role before submission.

Responsibility test: Under sections 2 and 2.1 of the Cosmetic Regulations, a Canadian business selling under its own brand may be the manufacturer; a person in Canada authorised to act in Canada for a foreign brand owner may also fall within that statutory definition. If neither exists, the importer—and, if there is no importer, certain Canadian manufacturing/processing parties—may be treated as the manufacturer for regulatory purposes. Verify the actual appointment, brand ownership and import-for-sale facts; a logistics “importer of record” label alone does not settle the regulatory definition.

Reuse foreign evidence without importing foreign conclusions

Use the following evidence-reuse and gap matrix to avoid paying for unnecessary duplicate work while identifying documents that cannot simply be transplanted from another market.

Existing material	Can be reused for	Canadian gap / decision
EU/UK safety report or test data	Technical evidence to support a Canadian safety review.	Not Canadian market authorisation or a substitute for the CNF; assess Canadian use, exposure and any requested safety evidence.
Supplier formula/INCI list	Ingredient identity and concentrations or valid CNF range codes.	Obtain confidential composition from formulator, resolve mixtures, compare each restricted ingredient and condition with Canadian Hotlist.
EU/US product artwork	Draft claims, warnings and ingredient disclosure.	Verify Canadian English/French mandatory particulars, label contact, allergen thresholds and claims; do not simply print existing artwork.
Previous CNF and Cosmetic Number	Identify whether amendment or discontinuation is appropriate.	Compare version, names, formula, contacts and sale status; a number is administrative, not approval.

Conditional attachment: When sections 22–24 of the Cosmetic Regulations require warnings or safe-use directions on labels or inserts, paragraph 30(1)(b) requires a copy or facsimile of the applicable labels and inserts with the notification. Check the final artwork and inserts, not only the INCI list.

Hotlist is a screening tool, not clearance: An ingredient missing from the Hotlist is not thereby proven safe or eligible for the cosmetic route. Assess the Food and Drugs Act, the Cosmetic Regulations and the product-specific risk, rather than treating a database result as approval.

2026 fragrance-allergen decision gate

Since 12 April 2026, the initial 24 specified fragrance allergens above 0.001% for leave-on or 0.01% for rinse-off cosmetics must be disclosed. From 1 August 2026, the expanded List 2 applies to new cosmetics; it applies to existing products from 1 August 2028. Assess total allergen content including constituents of essential oils/botanicals, the product’s new/existing status, and any grouped allergen rules. Applicable allergens must appear separately from “parfum” on labels and be reported in the CNF; do not assume an EU dossier automatically resolves Canadian artwork or notification fields.

CNF data nuance: Health Canada says that concentration information for certain reportable fragrance allergens may be omitted from the CNF, provided their presence above the threshold is identified; a concentration or range remains necessary where a concentration-related Hotlist condition applies. The supplier still needs sufficient information to calculate disclosure thresholds, including the sum for grouped allergens. This does not waive general concentration reporting for other cosmetic ingredients.

Sequence the work and control later changes

Decision gates: (1) Stop and classify if medicinal or pest-control claims, atypical route of administration or critical unknown ingredients make cosmetics uncertain. (2) Resolve before commercial release if a Hotlist condition, safety evidence, Canadian-party identity, label or allergen disclosure is unresolved; a CNF does not cure non-compliance. (3) Notify and monitor once the cosmetic route and launch readiness are substantiated. Section 31 requires revisions within 10 days after information becomes inaccurate, including cessation of Canadian sales, and a response to regulator requests within 10 days. Section 15.3 can prohibit continued sale when notification, revision or requested-information requirements are unmet. The submission itself carries no Health Canada fee, although outside professional work may cost money.

Distinct safety-evidence stop: Under section 29, failure to supply safety evidence by the date specified in a Health Canada request requires sales to cease; an official finding that the evidence is insufficient also requires cessation until further evidence is accepted. This is separate from the 10-day notification-information response under section 31; do not assume a safety-evidence request always has a 10-day deadline.

What a consultant should deliver—and what remains your decision

A meaningful advisory mandate produces a written classification rationale linked to actual claims; a Canadian responsibility map; an ingredient/Hotlist and safety-evidence gap register; a Canada-specific label/allergen change list; a product-variation and existing-CN comparison; and a sequenced proceed / remediate / seek classification clarification recommendation. It should specify what is confirmed, uncertain, and assigned to the manufacturer, importer or adviser. Actual form-keying, testing, artwork production and ongoing monitoring are distinct execution work.

For wider product regimes, see Canadian product compliance and market access. For a different jurisdiction, compare EU CPNP notification strategy.

Questions on difficult notification decisions

Can a consultant submit the CNF for an overseas brand without becoming the manufacturer?

An authorised agent may submit it, but Health Canada requires the correct manufacturer/importer details and a Canadian manufacturer or importer address. Agree and document the statutory roles; a filing agent is not automatically the responsible manufacturer.

Must I wait for a Cosmetic Number before first sale?

Section 30 sets a deadline of 10 days after first sale, not a pre-sale approval process. However, classification, safety, restrictions and labelling must already be compliant; submitting a CNF or receiving a number does not establish this.

Does a European CPSR or CPNP notification replace Canada’s CNF?

No. It may contribute useful test, formulation or safety evidence, but a Canada-specific classification, Hotlist and label review and Canadian CNF remain separate tasks.

Can a lipstick range with different shades use one CNF?

Potentially. Health Canada allows one CNF where brand/product name, base formula and other notification particulars are the same and variations are limited to colour, scent or flavour. Otherwise separate CNFs may be necessary; check the precise conditions.

When all three official single-notification conditions are met—same name/trademark, same base formula with only slight colour/fragrance/flavour differences, and identical other CNF particulars—Health Canada also says adding or removing variants from the line does not itself require an amendment if no new ingredients are introduced. A new ingredient or a change to other filed information requires reassessment.

What if a formula, brand name, importer or Canadian sales status changes?

Compare it against the filed CNF. Where information becomes inaccurate, section 31 requires a revised notification within 10 days; cessation of sale is expressly included. Preserve the Cosmetic Number and a dated change log.

Official regulatory references

Strategic guidance, not a product-specific Health Canada classification or approval.